BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc.: According to the report, the global skincare devices market was valued at US$ 11.4 Bn in 2020 and is projected to expand at a CAGR of 9.9% from 2021 to 2028.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Insulin is a hormone produced by human pancreas that controls the amount of glucose levels in the bloodstream, and regulates human body’s metabolism of fats, proteins, and carbohydrates.

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced it is among the first group of companies worldwide to receive approval of its net-zero targets by the Science Based Targets initiative.

BeiGene, a global oncology biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, announced that the U.S. Food and Drug Administration has deferred action on the Biologics License Application for tislelizumab as a second-line treatment for patients with unresectable or metastatic esophageal squamous cell carcinoma.

Allos Pharma Inc (“Allos”), a late-stage pharmaceutical company developing therapeutics for neurodevelopmental disorders, announces presentation of “Arbaclofen produces clinically meaningful improvements in individuals with Fragile X” at the 18th NFXF International Fragile X Conference, July 14-17th , 2022.

Purple Biotech Ltd. today announced that following the decision by Isaac Israel, former Chief Executive Officer to step down from his CEO role and reduce the scope of his engagement with the Company for personal reasons, effective July 10, 2022, Gil Efron,

Theratechnologies Inc. today reported business highlights and financial results for the second quarter and first half of fiscal year 2022 ended May 31, 2022. All figures are in U.S. dollars unless otherwise stated.

Orcosa Inc. (“Orcosa” or the “Company”), a clinical-stage life sciences company improving patient outcomes through its next generation drug delivery technology – the Rapid Infusion Technology (RITe™) Platform – today announced the appointment of Dr. Andrew C. von Eschenbach, former Commissioner of the U.S. Food and Drug Administration (“FDA”) as Senior Advisor.

Alvotech, a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced the expansion of its board of directors as part of its transition from a private to a publicly traded company.

Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that pharmacokinetic (PK) data from the single ascending dose portion of a Phase 1 study with its novel, broad-spectrum, orally administered antiviral candidate CC-42344 for the treatment of pandemic and seasonal influenza A support the potential for once-daily dosing.